BIT 3.33% 3.1¢ biotron limited

new hepatitis c drugs sold in france fr 22,000

  1. 187 Posts.
    lightbulb Created with Sketch. 1
    What does this make Biotron worth!

    New hepatitis C drugs from Merck & Co. and Johnson & Johnson (JNJ) are being sold in France for 22,000 euros ($31,271) and more, a precedent some doctors say may limit access after the medicines are approved throughout Europe.

    J&J and Vertex Pharmaceuticals Inc. (VRTX)?s telaprevir costs 22,000 euros under a French program for seriously ill patients for whom there is no other effective treatment on the market, according to patient association SOS Hepatites. Merck & Co. said its boceprevir costs 30,000 euros under the same program.

    Merck, J&J?s New Hepatitis C Treatment Fetches $31,000 in France
    By Naomi Kresge and Carol Matlack - Apr 5, 2011 6:15 AM GMT+1000 Bloomberg 6/april 2011
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.1¢
Change
0.001(3.33%)
Mkt cap ! $27.06M
Open High Low Value Volume
3.1¢ 3.2¢ 3.1¢ $2.209K 70.46K

Buyers (Bids)

No. Vol. Price($)
1 230277 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 828 1
View Market Depth
Last trade - 10.38am 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.